Literature DB >> 6114260

Thromboxane synthase inhibition in patients with atherosclerotic heart disease.

J B Knudsen, A Juhl, J Gormsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6114260     DOI: 10.1016/s0140-6736(81)90375-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Introduction: thromboxane in biological systems and the possible impact of its inhibition.

Authors:  M Verstraete
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

2.  Dazoxiben: a pharmacological tool or clinical candidate?

Authors:  H M Tyler
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

3.  Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.

Authors:  M J Parry
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.